CLINICAL IMMUNOLOGY
Topic 1: Multiple Sclerosis
LECTURE 1: OVERVIEW OF MS CLINICAL ASPECTS Monday, 28/10/2019
Affects 2-3 million individuals globally 1:1000 in the Netherlands diagnosed with MS; affects women more
than men (2-3 : 1), disease of the young (20-40 yo)
CNS disease in the spinal cord; primary
pathology: INFLAMMATORY
DEMYELINATION of axonal myelin
disrupted axonal function due to
demyelinating lesions, detectable in MRI
Secondary pathological process: NON-
INFLAMMATORY DEGENERATION not so
visible in MRI; seen as atrophic lesions only if
it’s severe enough
Degeneration in MS: chronic demyelination of axons + gliosis of astrocytes + chronic activation of microglia
MRI localizations to look for MS lesions:
a. Periventricular
b. Juxtacortical – cortical (below or in the cerebral cortex)
c. Infratentorial (cerebellum & brainstem)
d. Spinal cord
Causes of MS:
a. Familial e.g. in monozygotic twins, 30% chance to develop MS among them, 2-5% increased risk if a
first-degree relative is affected
b. Environmental further away from equator, lower vit D status affect the risk of MS; viruses (EBV),
smoking (also associated with worse MS outcome), early obesity (e.g. since childhood)
c. Genes HLA region on chromosome 6 (also associated with many other autoimmune diseases, in
addition to MS); allelic variants in HLA-DRA locus is identified as risk factors for MS development –
more variants = more likely to develop MS
Symptoms of MS:
a. Optic neuritis (70% of all cases complains of having this; if one
has optic neuritis, there’s 50% chance to have MS diagnosis
later, thus require thorough MRI scan) decreased acuity,
central blurry-ness, loss of colour discrimination, retroorbital
pain
Eye movements disorder diplopia (d/t brainstem MS
lesion, usually in younger patients)
b. Lhermitte’s sign (if lesion in spinal cord) flexing the neck
(extend the spinal cord) causes the “electrical transmission”
down the back; MS suspicion if Lhermitte (+) in young patients,
Ddx for Lhermitte (+):
c. Motor symptoms (d/t demyelinating lesions down the motor
tract) loss of strength
d. Bladder-sexual dysfunction (one of the most common)
incontinence, sexual dysfunction
e. Psychological function disorders attention deficit, memory
loss, disturbed language functions, unable to multitask/slower
functioning
f. Fatigue (most common – albeit invisible): high impact, but
cause is unknown
, CLINICAL IMMUNOLOGY
Topic 1: Multiple Sclerosis
Symptoms arise due to inflammation within CNS semi-acute attack; origin: optic nerve, brain stem, spinal
cord. Mostly comes to the clinic with exacerbation of neurological symptoms keep on increasing over a few
weeks, then stagnates (complete/incomplete remission) before it comes up again
MS courses:
a. RRMS (relapsing remitting MS – most
common) inflammatory
predominance; unpredictable accidents
b. SPMS (secondary progressive MS)
degenerative predominance
c. PPMS (primary progressive MS)
typically older, male patients
How to diagnose MS:
Dx criteria: McDonald criteria (see below)
Monitored over 1 year
Diagnosis of MS has to be
reassured, both clinically &
radiologically, before
communicating to the patient
report this as CIS/clinically
isolated syndrome (symptoms +
w/o radiological evidence) or
RIS/radiological isolated
syndrome (radio + w/o
symptoms)
, CLINICAL IMMUNOLOGY
Topic 1: Multiple Sclerosis
Presence of oligoclonal bands in CSF if
oligoclonal bands concentration is high,
it is indicative for MS tx
Oligoclonal band: proteins that present
when there is inflammatory lesion of
CNS, when coupled with demyelinating
lesion evidence in MRI and/or MS
symptoms = MS
Other cases that allows presence of
oligoclonal band in CSF: … (?)
Has to make sure of both “dissemination in space & time”
a. Dissemination in space demyelinating lesions visible in 2 out of 4 localizations in MRI
b. Dissemination in time >1x relapse OR new lesions on follow-up MRI, contrast-enhancing lesion +
non-enhancing lesions at the same time
Contrast-enhancing lesion: active lesion/newly formed
Non-contrast-enhancing lesion: older lesion, but we don’t know how old
Tx aimed at RIS/CIS has to be weighed carefully
harm vs. benefit, although the risk of MS
development in those with RIS/CIS history is
very high
Diagnosis of PPMS has different Dx criteria:
a. Progression (+)
b. 2/3 the criteria above (time OR space OR
oligoclonal band)
MS follow up:
a. Clinical: frequency depending on
severity
b. Radiological (after 3 months)
c. Biochemical (biomarkers: neuro filament
light elevated when axon is broken
down, increased in serum & CSF)
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller oddsters. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $4.27. You're not tied to anything after your purchase.